Liu 2009a.
Methods | RCT, parallel design | |
Participants | 230 patients, scheduled to undergo outpatient shoulder arthroscopy under interscalene block Excluded: < 18 yrs, > 75 yrs, patient refusal, pregnancy, dementia, severe pulmonary disease, and known pre‐existing neurological disorders involving the operative limb |
|
Interventions | Ultrasound (n = 115) vs nerve stimulation group (n = 115) Interscalene block of axillary, musculocutaneous, ulnar, radial and median nerves with mepivacaine 1.5% with 1:300,000 epinephrine and NaCO3 (1 meq/10mL); for participants < 50 kg, total dose of 45 ‐ 55 ml was used for patients ≥ 50 kg, total dose of 55 ‐ 65 mL was used Ultrasound: A linear 10 ‐ 13 MHz US probe was used to visualize the brachial plexus. Initial US visualization was at interscalene area. 5 cm 22 G needle placed through middle scalene muscle, into interscalene groove, in‐plane US guidance to visualize the entire needle. LA injected in divided doses with frequent aspiration under ultrasound visualization. Nerve stimulation (Stimuplex): 5 cm 22 G insulated needle placed into interscalene groove. Current decreased to range between 0.2 mA and 0.5 mA. If not still present then needle adjusted. LA injected in divided doses with frequent aspiration |
|
Outcomes |
|
|
Notes | No details of experience of anaesthetists giving nerve blocks | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | Computer‐generated random number table |
Allocation concealment (selection bias) | Unclear risk | Used a “sealed envelope sequence”. No further details |
Blinding of participants and personnel (performance bias):adequacy of block, need for supplementation | High risk | Not possible to blind anaesthetist |
Blinding of participants and personnel (performance bias):Complications | High risk | Not possible to blind anaesthetist |
Blinding of participants and personnel (performance bias): time outcomes | High risk | Not possible to blind anaesthetist |
Blinding of outcome assessment (detection bias): adequacy of block, supplementation of block | Low risk | Adequacy of block assessed by an investigator who was unaware of group allocation |
Blinding of outcome assessment (detection bias): Complications | Low risk | Neurological complications assessed and analyzed by blinded investigator |
Blinding of outcome assessment (detection bias): time outcomes | Unclear risk | Time to perform block assessed by an investigator not performing block but no details as to whether they were blinded |
Incomplete outcome data (attrition bias) All outcomes | Low risk | Some losses to follow‐up but relatively small number and details given |
Selective reporting (reporting bias) | Unclear risk | Pre‐published protocol not sought |
Baseline characteristics | Low risk | All comparable |
Funding sources | Low risk | None apparent |
Operator expertise | Unclear risk | No details of who, how many and experience of anaesthetists giving blocks |